Article Details

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study ...

Retrieved on: 2024-06-12 19:07:38

Tags for this article:

Click the tags to see associated articles and topics

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study .... View article details on hiswai:

Excerpt

NOVATO, LONDON, UK - Ultragenyx Pharmaceutical Inc. and Mereo BioPharma Group plc today announced positive 14-month results from the Phase 2 ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo